Features of innate and adaptive immunity in patients with moderate course of COVID-19 with various degrees of lung tissue damage

Nadezhda A. Skripkinа , Ludmila P. Sizyakinа , Elena A. Antonova , Dmitry V. Sizyakin , Vita Ya. Zakurskayа

Cytokines and inflammation ›› 2022, Vol. 19 ›› Issue (1-4) : 69 -74.

PDF
Cytokines and inflammation ›› 2022, Vol. 19 ›› Issue (1-4) : 69 -74. DOI: 10.17816/CI2022221-4-10
Articles
research-article

Features of innate and adaptive immunity in patients with moderate course of COVID-19 with various degrees of lung tissue damage

Author information +
History +
PDF

Abstract

Objective: to study changes in innate and adaptive immunity in patients with a moderate course of COVID-19 with varying degrees of lung tissue damage. 40 patients with a moderate form of COVID-19 and varying degrees of damage to the lung tissue (up to 25% and up to 50%) and 30 patients from the control group (healthy donors) were examined using methods: computed tomography of the lungs, evaluation of a complete blood count, biochemical parameters, immunological studies, statistical. Differences in all patients with the control group consisted in a decrease in the absolute content of lymphocytes, in a significant increase in the relative content of natural killers and cytokine imbalance. The most significant differences were registered in the content of IL-6, depending on the degree of damage to the lung tissue. A smaller area of lung damage reflects a milder course of the disease, which does not exclude the need for dispensary observation and rehabilitation after discharge.

Keywords

coronavirus infection / COVID-19 / computed tomography

Cite this article

Download citation ▾
Nadezhda A. Skripkinа, Ludmila P. Sizyakinа, Elena A. Antonova, Dmitry V. Sizyakin, Vita Ya. Zakurskayа. Features of innate and adaptive immunity in patients with moderate course of COVID-19 with various degrees of lung tissue damage. Cytokines and inflammation, 2022, 19(1-4): 69-74 DOI:10.17816/CI2022221-4-10

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Никифоров В.В., Суранова Т.Г., Чернобровкина Т.Я., Янковская Я.Д., Бурова С.В. Новая коронавирусная инфекция (Covid-19): клинико-эпидемиологические аспекты // Архивъ внутренней медицины. – 2020. – № 10 (2 (52)). – С. 87-93. Nikiforov V.V., Suranova T.G., Chernobrovkina T.Ya., Yankovskaya Y.D., Burova S.V. New coronavirus infection (Covid-19): clinical and epidemiological aspects // Archives of Internal Medicine. 2020. Vol.10 (2 (52)). P. 87-93.

[2]

Сизякина Л.П., Закурская В.Я., Скрипкина Н.А., Антонова Е.А. Уровень ферритина как предиктор тяжелого течения COVID-19 // Иммунология. – 2021. – Т. 42 (5). – С. 518–525. Siziakina L.P., Zakurskaya V.Ya., Skripkina N.A., Antonova E.A. Ferritin level as a predictor of severe COVID-19 // Immunology. 2021; Vol. 42 (5). P. 518–525.

[3]

Сизякина Л.П., Закурская В. Я., Скрипкина Н.А., Антонова Е.А., Сизякин Д.В. Клинико-иммунологическая характеристика среднетяжелых форм COVID-19 при различных уровнях маркера тканевой деструкции – лактатдегидрогеназы // Медицинский вестник Юга России. – 2021. – Т.12(4). – С. 108-115. Siziakina L.P., Zakurskaya V.Ya., Skripkina N.A., Antonova E.A., Sizyakin D.V. Clinical and immunological characteristics of moderate forms of COVID-19 at different levels of tissue destruction marker - lactate dehydrogenase // Medical Bulletin of the South of Russia. 2021; Vol.12(4), P.108-115.

[4]

Fara A., Mitrev Z., Rosalia R.A., Assas B.M. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines// Open Biology. 2020. Vol. 10(9) P 200160.

[5]

Han H., Ma Q., Li C., Liu R., Zhao L., Wang W., Zhang P., Liu X., Gao G., Liu F., Jiang Y., Cheng X., Zhu C., Xia Y. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors// Emerging microbes & infections. 2020. Vol. 9(1), P. 1123–1130.

[6]

Hernández-Ruiz M., Zlotnik A. Mucosal Chemokines// Journal of interferon & cytokine research. 2017. Vol. 37(2), P. 62–70.

[7]

Hu B., Huang S., Yin L. The cytokine storm and COVID-19// J Med Virol. 2021. Vol. 93(1), P. 250-256.

[8]

Luo X. H., Zhu Y., Mao J., Du R. C. T cell immunobiology and cytokine storm of COVID-19// Scandinavian journal of immunology. 2021. Vol. 93(3), e12989.

[9]

Machado-Carvalho L, Roca-Ferrer J, Picado C. IL-4/IFN-γ inflammatory cytokine profile induces a deficient regulation of the IL-1β/IL-1RI/EP2/COX-2 pathway in nasal mucosa // Respiratory medicine. 2019. Vol. 150, P.136-140.

[10]

Ochani, R., Asad, A., Yasmin, F., Shaikh S., Khalid H., Batra S., Sohail M. R., Mahmood S. F., Ochani R., Hussham Arshad M., Kumar A., Surani S. COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management// Le infezioni in medicina. 2021. Vol. 29(1), P. 20–36.

[11]

Patterson B. K., Guevara-Coto J., Yogendra R., Francisco E. B., Long E., Pise A., Rodrigues H., Parikh P., Mora, J., Mora-Rodríguez R. A. Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning //Frontiers in immunology. 2021. Vol. 12.

[12]

Vallejo A., Vizcarra P., Quereda C., Moreno A., Casado J.L.; CoVEX study group. IFN-γ+ cell response and IFN-γ release concordance after in vitro SARS-CoV-2 stimulation// European journal of clinical investigation. 2021, Vol. 51(12), P.13636.

[13]

Zheng Y., Wang L., Ben S. Meta-analysis of chest CT features of patients with COVID-19 pneumonia // Journal of medical virology/ 2021/ Vol. 93,1, P. 241-249.

RIGHTS & PERMISSIONS

Skripkinа N.A., Sizyakinа L.P., Antonova E.A., Sizyakin D.V., Zakurskayа V.Y.

AI Summary AI Mindmap
PDF

118

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/